PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OM vs. SGMO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


OMSGMO
YTD Return-85.36%277.32%
1Y Return-84.26%484.55%
3Y Return (Ann)-75.49%-40.72%
Sharpe Ratio-0.683.01
Sortino Ratio-0.903.55
Omega Ratio0.871.40
Calmar Ratio-0.854.64
Martin Ratio-1.4110.74
Ulcer Index60.07%42.96%
Daily Std Dev124.74%153.36%
Max Drawdown-99.30%-99.40%
Current Drawdown-98.76%-95.87%

Fundamentals


OMSGMO
Market Cap$45.13M$564.28M
EPS-$2.74-$1.38
Total Revenue (TTM)$114.73M$2.88M
Gross Profit (TTM)$35.53M-$5.20M
EBITDA (TTM)-$159.08M-$133.70M

Correlation

-0.50.00.51.00.3

The correlation between OM and SGMO is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

OM vs. SGMO - Performance Comparison

In the year-to-date period, OM achieves a -85.36% return, which is significantly lower than SGMO's 277.32% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%JuneJulyAugustSeptemberOctoberNovember
-77.98%
215.44%
OM
SGMO

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OM vs. SGMO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Outset Medical, Inc. (OM) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OM
Sharpe ratio
The chart of Sharpe ratio for OM, currently valued at -0.68, compared to the broader market-4.00-2.000.002.00-0.68
Sortino ratio
The chart of Sortino ratio for OM, currently valued at -0.90, compared to the broader market-4.00-2.000.002.004.00-0.90
Omega ratio
The chart of Omega ratio for OM, currently valued at 0.87, compared to the broader market0.501.001.502.000.87
Calmar ratio
The chart of Calmar ratio for OM, currently valued at -0.85, compared to the broader market0.002.004.006.00-0.85
Martin ratio
The chart of Martin ratio for OM, currently valued at -1.41, compared to the broader market0.0010.0020.0030.00-1.41
SGMO
Sharpe ratio
The chart of Sharpe ratio for SGMO, currently valued at 3.01, compared to the broader market-4.00-2.000.002.003.01
Sortino ratio
The chart of Sortino ratio for SGMO, currently valued at 3.55, compared to the broader market-4.00-2.000.002.004.003.55
Omega ratio
The chart of Omega ratio for SGMO, currently valued at 1.40, compared to the broader market0.501.001.502.001.40
Calmar ratio
The chart of Calmar ratio for SGMO, currently valued at 4.70, compared to the broader market0.002.004.006.004.70
Martin ratio
The chart of Martin ratio for SGMO, currently valued at 10.74, compared to the broader market0.0010.0020.0030.0010.74

OM vs. SGMO - Sharpe Ratio Comparison

The current OM Sharpe Ratio is -0.68, which is lower than the SGMO Sharpe Ratio of 3.01. The chart below compares the historical Sharpe Ratios of OM and SGMO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00JuneJulyAugustSeptemberOctoberNovember
-0.68
3.01
OM
SGMO

Dividends

OM vs. SGMO - Dividend Comparison

Neither OM nor SGMO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OM vs. SGMO - Drawdown Comparison

The maximum OM drawdown since its inception was -99.30%, roughly equal to the maximum SGMO drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for OM and SGMO. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%JuneJulyAugustSeptemberOctoberNovember
-98.76%
-88.72%
OM
SGMO

Volatility

OM vs. SGMO - Volatility Comparison

The current volatility for Outset Medical, Inc. (OM) is 29.62%, while Sangamo Therapeutics, Inc. (SGMO) has a volatility of 61.52%. This indicates that OM experiences smaller price fluctuations and is considered to be less risky than SGMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%120.00%JuneJulyAugustSeptemberOctoberNovember
29.62%
61.52%
OM
SGMO

Financials

OM vs. SGMO - Financials Comparison

This section allows you to compare key financial metrics between Outset Medical, Inc. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items